VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
UENO, NAOTO T
One or more keywords matched the following items that are connected to
UENO, NAOTO T
Item Type
Name
Concept
MAP Kinase Kinase 2
Concept
MAP Kinase Kinase Kinase 1
Concept
MAP Kinase Kinase 7
Concept
MAP Kinase Kinase Kinases
Concept
MAP Kinase Kinase 4
Concept
MAP Kinase Kinase 1
Academic Article
MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model.
Academic Article
Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.
Academic Article
TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction.
Academic Article
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development.
Academic Article
XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway.
Academic Article
TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development.
Academic Article
The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling.
Academic Article
PKC delta is essential for Dishevelled function in a noncanonical Wnt pathway that regulates Xenopus convergent extension movements.
Academic Article
MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.
Academic Article
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Academic Article
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Search Criteria
MAP Kinase Kinase 7